硬膜外脊髓电刺激治疗痉挛状态:文献系统综述
本系统综述检索 Embase、CENTRAL 和 MEDLINE,纳入 34 项使用硬膜外脊髓电刺激治疗痉挛状态的研究。汇总主观痉挛改善率为 78%(95%CI 64%-91%;I²=77%),步行能力改善率为 73%(65%-80%;I²=50%),脊髓病因患者结局优于脑病因患者;作者认为该技术可能安全有用,但研究异质性大、质量低,需进一步研究。
要点
- 汇总主观痉挛改善率为 78%(95%CI 64%-91%;I²=77%)。
- 汇总步行能力改善率为 73%(65%-80%;I²=50%)。
- 脊髓病因患者结局优于脑病因患者,高达 10% 患者出现感染和硬件故障等并发症。
核心结论
- 作者认为硬膜外脊髓电刺激可能是治疗痉挛状态的安全有用工具,但研究间存在显著异质性且研究质量低。
- 作者指出需进一步研究以全面评估该技术,包括不同痉挛病因下的各种刺激范式。
研究设计与样本
- 系统综述,检索 Embase、CENTRAL 和 MEDLINE 数据库。
- 纳入使用硬膜外脊髓电刺激治疗痉挛状态的研究,最终分析纳入 34 项研究。
- 排除研究功能性电刺激、经皮脊髓电刺激和痉挛状态动物模型的研究,以及使用脊髓电刺激治疗疼痛等其他症状的研究。
主要发现
- 汇总主观痉挛改善率为 78%(95%CI 64%-91%;I²=77%)。
- 汇总 H 反射阈值升高或 Hoffman 反射/肌肉反应波比值降低率为 40%(95%CI 7%-73%;I²=88%)。
- 汇总步行能力改善率为 73%(65%-80%;I²=50%)。
- 脊髓病因患者结局优于脑病因患者。
- 高达 10% 的患者出现并发症,包括感染和硬件故障。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究间存在显著异质性(主观痉挛改善 I²=77%;H 反射阈值升高或 Hoffman 反射/肌肉反应波比值降低 I²=88%;步行能力改善 I²=50%)。
- 研究质量低。
- 需进一步研究以全面评估该技术,包括不同痉挛病因下的各种刺激范式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spasticity is a form of muscle hypertonia secondary to various diseases, including traumatic brain injury, spinal cord injury, cerebral palsy, and multiple sclerosis. Medical treatments are available; however, these often result in insufficient clinical response. This review evaluates the role of epidural spinal cord stimulation (SCS) in the treatment of spasticity and associated functional outcomes. METHODS: A systematic review of the literature was performed using the Embase, CENTRAL, and MEDLINE databases. We included studies that used epidural SCS to treat spasticity. Studies investigating functional electric stimulation, transcutaneous SCS, and animal models of spasticity were excluded. We also excluded studies that used SCS to treat other symptoms such as pain. RESULTS: Thirty-four studies were included in the final analysis. The pooled rate of subjective improvement in spasticity was 78% (95% confidence interval, 64%-91%; I2 = 77%), 40% (95% confidence interval, 7%-73%; I2 = 88%) for increased H-reflex threshold or decreased Hoffman reflex/muscle response wave ratio, and 73% (65%-80%; I2 = 50%) for improved ambulation. Patients with spinal causes had better outcomes compared with patients with cerebral causes. Up to 10% of patients experienced complications including infections and hardware malfunction. CONCLUSIONS: Our review of the literature suggests that SCS may be a safe and useful tool for the management of spasticity; however, there is significant heterogeneity among studies. The quality of studies is also low. Further studies are needed to fully evaluate the usefulness of this technology, including various stimulation paradigms across different causes of spasticity.
引用
- Jung Y, Breitbart S, Malvea A, et al. Epidural Spinal Cord Stimulation for Spasticity: a Systematic Review of the Literature. World Neurosurg. 2024. PMID: 38181878. doi:10.1016/j.wneu.2023.12.158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。